Synthol and other site enhancement oils (SEOs)
July 27, 2026
Site enhancement oils (SEOs)
Site-enhancement oils (SEOs), also referred to as “cosmetic doping substances” or “body fillers”, are oil-based substances injected into tissue to change the appearance of a body part, for example, to make a muscle appear bigger or rounder. The term “cosmetic doping” describes the aim to enhance looks without improving muscle strength or performance. [1, 2]
Literature reports a wide range of oil mixtures that have been injected for cosmetic purposes. A common product discussed in case reports and reviews is Synthol (or Syntherol), which is described as a mixture of ~85% oil/fat, 7.5% lidocaine, and 7.5% alcohol (*). Other unregulated oils, such as mineral or paraffin oils, have also been used [2].
*Note: The exact composition can vary across products and batches, since SEOs are often obtained from illicit, unregulated sources.
SEOs in ‘Cosmetic Enhancement’ – Why are they used?
Reported motives for SEO use vary, and different oils are also used for various purposes [2]:
- muscle enhancement
- genital enhancement
- breast enhancement
- anti-aging purposes
People who inject SEOs/ fillers for muscle enhancement are often male, and in many cases current or former bodybuilders, using oils for bodybuilding-related appearance goals targeting specific muscles or to “fix” perceived weak points [2].
Case examples:
- A 40-year-old semi-professional bodybuilder self-injected sterilized sesame seed oil into numerous intramuscular sites over 8 years. [3] A systemic infection and painful, red, swollen skin on the right upper arm forced him to discontinue weightlifting.
- A 46-year-old woman injected baby oil into breasts in an attempt to restore their perkiness and fullness. A foreign-body granulation reaction later required an operation [4].
Adverse effects
SEOs can trigger a foreign body reaction at the injection site, along with a range of other harms across different organs [2]. Effects range from local tissue damage to serious systemic complications that can also emerge years later. Documented harms include:
- Local tissue reactions: Granulomas, fibrosis, ulceration, pain, swelling, and deformity at (and sometimes beyond) the injection site
- Systemic complications: Hypercalcemia, renal failure, respiratory distress, lung injury, and anaphylactic reactions
- Sexual adverse effects: Penile pain, deformity, voiding dysfunction, and sexual dysfunction following genital injections
Management and treatment
Non-surgical care for SEO complications include antibiotics, corticosteroids, and compression therapy that are used to contain the inflammatory attacks, the spread of the oil, and the resulting lipogranulomatosis [5]. Surgical treatments aim to halt the condition’s progression while preventing chronic ulcers and secondary infection [5].
Mikko Lemettilä, MSc (Pharm.Sci.), A-Clinic Foundation
- Figueiredo, V. C., & Da Silva, P. R. P. (2014). Cosmetic doping—When anabolic-androgenic steroids are not enough. Substance Use & Misuse, 49(9), 1163–1167. https://doi.org/10.3109/10826084.2014.916522
- Brennan, R., Overbye, M., Van Hout, M. C., & McVeigh, J. (2021). “A slippery slope”: A scoping review of the self-injection of unlicensed oils and fillers as body enhancement. Performance Enhancement & Health, 8(4), Article 100185. https://doi.org/10.1016/j.peh.2020.100185
- Banke, I. J., Prodinger, P. M., Waldt, S., Weirich, G., Holzapfel, B. M., Gradinger, R., & Rechl, H. (2012). Irreversible muscle damage in bodybuilding due to long-term intramuscular oil injection. International journal of sports medicine, 33(10), 829–834. https://doi.org/10.1055/s-0032-1311582
- Agac, A., Akturan, S., Guclu, T. H., Alyanak, A., Gobut, H., & Gulten, K. (2017). The First Reported Case of Breast Granulomas Secondary to Huge Amount of Baby Oil Self-injection. International Biological and Biomedical Journal, 3(1), 44–46.
- Schäfer, C. N., Hvolris, J., Karlsmark, T., & Plambech, M. (2012). Muscle enhancement using intramuscular injections of oil in bodybuilding: Review on epidemiology, complications, clinical evaluation and treatment. European Surgery, 44(2), 109–115. https://doi.org/10.1007/s10353-011-0033-z
Like, share